Submit a Manuscript to the Journal
Ophthalmic Genetics
For a Special Issue on
Festschrift: Dedicated to the Life and Work of A. Linn Murphree, MD
Manuscript deadline
03 October 2022

Special Issue Editor(s)
Jesse L. Berry,
Children’s Hospital Los Angeles
[email protected]
Francis Munier,
Jules-Gonin Eye Hospital
[email protected]
Festschrift: Dedicated to the Life and Work of A. Linn Murphree, MD
Ophthalmic Genetics is seeking submissions for an upcoming special issue on Retinoblastoma to celebrate the life and work of A. Linn Murphree, MD, which will be co-edited by Jesse L. Berry, MD and Francis Munier, MD. Linn was a force in Ocular Oncology, having a role in cloning the first tumor suppressor gene, systemic chemotherapy for Retinoblastoma - ushering in wide-field pediatric fundus photography and developing a localized delivery system for chemotherapy (the chemoplaque) that is currently in clinical trial. He was a fine teacher, a collaborator and a patient advocate.
We welcome submissions (list is not exhaustive) examining any of following areas:
• Retinoblastoma
• Ocular Cancers
• Cancer Genetics
• Novel Therapeutics
• Novel Diagnostics
• Patient Experience
• Oculogenetics
Looking to Publish your Research?
Find out how to publish your research open access with Taylor & Francis Group.
Choose open accessSubmission Instructions
Select "Special Issue: Festschrift: Dedicated to the Life and Work of A. Linn Murphree, MD” when submitting your paper to ScholarOne.
View the latest tweets from tandfmedicine
Read more
Read more
Read more